There is rarely one universal test that proves a cancer treatment is working. Doctors usually combine several types of information and interpret them in the context of the particular cancer and treatment.
Symptoms and day-to-day function
An improvement in pain, breathing, appetite, energy or another cancer-related symptom may suggest benefit. A worsening symptom may prompt earlier assessment.
Symptoms are important but not definitive. Treatment side effects, infection, another health condition or anxiety can change how someone feels. Some cancers cause few symptoms even when they are changing.
Clinical examination
An examination may show whether a lump has changed, fluid has built up, swelling has improved, or a person’s general condition is different. What can be assessed depends on where the cancer is.
Blood tests and tumour markers
Routine blood tests can show how organs and bone marrow are coping with treatment. In some cancers, a tumour marker can provide additional information.
Tumour markers are not suitable for every cancer. They can change for reasons other than cancer, and a result should not usually be interpreted in isolation. The pattern over time may be more useful than one number.
Scans
CT, MRI, PET, ultrasound, X-ray or other imaging may be used, depending on the clinical question. The team compares the new images with earlier ones and looks for shrinkage, stability, growth or new areas.
The timing matters. A scan performed too early may be difficult to interpret, and some treatments can temporarily create changes that resemble worsening.
Pathology and other specialist tests
In certain situations, a repeat biopsy, endoscopy, bone marrow test or specialised blood test may be needed. These are used when the result could clarify what is happening or alter the plan, not as a routine step for everyone.
What counts as success depends on the aim
If treatment is intended to cure cancer, doctors may be looking for no detectable disease and for it not to return over time. If treatment is intended to control advanced cancer, stable disease, symptom improvement or slower growth may be a meaningful success.
The most important question is not always “Has it disappeared?” It is “Is the treatment achieving the outcome it was chosen to achieve, with an acceptable effect on the person receiving it?”
Questions to ask
- What is the aim of my treatment?
- Which tests will show whether it is helping?
- When is the first useful assessment?
- What result would lead us to continue or change treatment?
- Which symptoms should I report before the planned review?
Your clinical team should explain both the evidence they are using and the uncertainty that remains.